Symbicort was first FDA-approved in 2006 as ... a long-acting beta2-agonist bronchodilator with a fast action, in a single inhaler. A Viatris spokesperson said: "Viatris obviously disagrees ...
Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...
“Flutiform and Symbicort metered dose inhalers contain a type of propellant that has a more powerful greenhouse effect than other metered dose inhalers that contain similar medicines. Dry powder ...